我国生物医药产品的发展及监管

Development and regulation of biological products in China

摘要: 介绍国内外生物医药产业的发展进程与现状，阐述我国生物医药的监管制度。从生物制品的注册审批、上市前的批签发、质量控制标准、及上市后的不良反应监测等制度作一综述，为我国生物医药及产品的发展与监管提供相应的借鉴参考。
- 中国 /
- 生物制品 /
- 发展 /
- 监管
Abstract: The development and the status quo of domestic and foreign biopharmaceutical industries are introduced, and the supervision system of biological medicine in China is elaborated. The approval of biologics, the pre-marketing batch-release system for biological products, quality control standards, as well as the post-marketing adverse reaction monitoring system are reviewed, aiming to provide some references for the development and regulation of Chinese biopharmaceutical products.
- China /
- biological products /
- development /
- regulatory

[1]	Zhan ZS,Ji QS,Pu CY,et al.The development status and prospect of biotechnology drugs[J].J Pract Med Pharm(实用医药杂志),2011,28(2):168-170.
[2]	Li G.Global bio pharmaceutical industry prospects in 2012(2012年全球生物制药业前景光明)[N].China Pharm News(中国医药报),2012-03-28(A06).
[3]	Wen SM.The global development of the biopharmaceutical industry[J].China Biotechnol(中国生物工程杂志),2006,26(1):92-96.
[4]	Wang Y,Wu WJ,Li Q,et al.The research progress and trend of biotech drugs in recent years in China[J].Pharm Biotechnol(药物生物技术),2013,20(1):1-11.
[5]	Chang WH,Han P,Cao LZ.The past 30 years and the future of drug registration and R&D in China(1)[J].Chin J New Drugs(中国新药杂志),2010,19(23):2 127-2 131.
[6]	Jia LL,Yang Y,Dong GM.Study on improvement of national lot release regulations on biological products[J].Chin Pharm Aff(中国药事),2010,24(6):523-530.
[7]	Wang XJ,Cao Y,Guo ZP.The historical evolution of Chinese biological products national standard[J].Chin J Biol(中国生物制品学杂志),2013,26(4):582-584.
[8]	Chen XY,Dong Z,Hou YF.The history of security control and adverse reaction monitoring to the marketed Chinese biological product[J].Pharm Biotechnol(药物生物技术),2008,15(5):407-410.
[9]	Tang RY,Zhu CH.Analysis of China′s biopharmaceutical industry status quo and development constraints[J].Mod Prev Med(现代预防医学),2011,38(21):4 406-4 408,4 416.